prescription drugs
Colorado’s plan to import prescription drugs from Canada just got a boost, thanks to Congress
A provision in an obscure bill would require the Food and Drug Administration to set up an importation program
Opinion: Drugs don’t work if we can’t afford them
We can lower drug prices without jeopardizing innovations in medicines
How a rural Colorado town without a pharmacy is crowdsourcing to get meds
With no local access to prescription drugs, Walden residents are taking advantage of anyone’s trip to bigger cities to pick up medications for the rest of the town
Colorado’s program to stop patients from “doctor shopping” for opioids hasn’t been working, audit finds
Audit recommends legislation to require prescribers to use the database to track drug prescriptions — and add penalties if they don't
Colorado lawmakers wage multifront assault on high drug costs
While none of the efforts alone would result in broad-based, deep cuts, state officials estimate the combined impact of the various measures could save Coloradans between 20% and 40% in out-of-pocket costs
Opinion: Colorado needs a Prescription Drug Affordability Board to protect the public interest
Skyrocketing drug prices affect all Coloradans, and this is an opportunity for our legislators to do something about it.
Opinion: A prescription-drug price-control bill is the wrong answer for Colorado
Colorado shouldn’t be a test kitchen for a non-Coloradan’s political agenda.
Colorado already allows prescription drug imports from Canada. Lawmakers want to open it up to more countries.
Colorado and 11 other states want to expand programs to directly import medications, most of which are manufactured in other countries. The law passed in 2019 to allow Canadian imports hasn't yet been implemented.
Opinion: A bill in the Colorado legislature might have saved my son
When an opioid overdose strikes, naloxone can be the difference between life and death. Legislation could put it in more hands.
To fix soaring prescription costs, Colorado lawmakers have a new plan: A board to cap drug prices
A bill to create a Prescription Drug Affordability Review Board is expected to draw strong opposition from the pharmaceutical industry
Opinion: Coloradans should pay fair prices for prescription drugs
No one should be forced to fill a prescription instead of paying their rent or putting food on the table.
Sen. Jim Smallwood: Colorado’s drug-importation scheme is a political pipe dream
The deeper you dig into the idea, the more smoke and mirrors it becomes.
Colorado takes a step toward importing drugs from Canada, but the start date is still two years away
The Department of Health Care Policy and Financing predicts big prescription cost savings -- but not for the state’s Medicaid program
Federal prosecutors in Colorado, across the U.S. sue Walmart over role in opioid crisis
The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists "knew were invalid"
Colorado governor vetoes bill that sought to reduce prescription opioid abuse
Gov. Jared Polis wrote in a letter that he vetoed House Bill 1085 because of the impact it would have on health insurance premiums
Colorado’s rural pharmacies wrestle against big business to remain community cornerstones
1,230 rural pharmacies have closed since 2003, including 45 in Colorado. Some blame benefit management companies that reimburse for medications at less than they cost to buy.
Colorado’s coronavirus budget crunch is putting Democratic accomplishments at risk
The Joint Budget Committee will begin meeting next week to consider recommended spending cuts, but they still may not be enough to balance the budget
Colorado wants to let pharmacists write prescriptions for HIV prevention drugs
House Bill 1061 to make PrEP available at pharmacies without a doctor's visit is aimed at eliminating HIV infections in Colorado as prevention funding is cut and access plateaus
5 numbers that explain why Colorado lawmakers want more insight into prescription drug costs
Democrats are trying again this year to pass a bill requiring pharmaceutical companies to be more transparent about price increases and rebates